knowledge -WSS

knowledge

author：hotspot 2025-09-30 00:49:58 - browse：2

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Astellas still sees hope in its gene therapy after four deaths

WSS

Anthos stroke drug appears safer than common blood thinner

Sea level rise could wash away turtle breeding grounds around the world, researchers say

FDA approves first new drug developed for postpartum depression

Millions may soon lose Medicaid when they don't have to

FDA's Woodcock to retire early next year

Wegovy, Zepbound and weight loss drugs that preserve muscle

focus

knowledge

knowledge

New air purifier tech could be key to improving indoor air quality

How to fix the rural physician shortage in the U.S.

What does generative AI mean for health care? We asked experts

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Psychedelics group wrestles with new pharma identity

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

DIEP, the 'gold standard' of breast reconstruction, is under threat

In key trial, Verve's treatment lowers cholesterol levels in patients

Wildfire smoke exposes gaps in outdoor worker protections

Congress must reauthorize a committee to support older Americans

leisure time

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Congress must reauthorize a committee to support older Americans

Novo pauses ads for weight loss drug Wegovy amid demand

Mom launches Girl Scout troop for LGBTQ youth in Texas

Altering the blood type of lungs raises potential for universal organs for transplants

Surge of respiratory disease in China has likely explanation

leisure time

focus

hotspot

entertainment